首页> 外文期刊>Bone marrow transplantation >Yersinia pseudotuberculosis causing abscesses in a 31-year-old patient in the post-immunosuppression period after allogeneic HSCT.
【24h】

Yersinia pseudotuberculosis causing abscesses in a 31-year-old patient in the post-immunosuppression period after allogeneic HSCT.

机译:异基因HSCT免疫抑制后,一名31岁患者的假性耶尔森氏菌引起脓肿。

获取原文
获取原文并翻译 | 示例
       

摘要

The risk of infection after allo-SCT is determined by the underlying disease, intensity of earlier treatments and by the chosen transplantation modality. High risk of infection even after hematopoietic reconstitution is characteristic compared with patients undergoing conventional chemotherapy or auto-SCT. On account of mucosal damage, functional deficiencies of granulocytes, functional asplenia and qualitative and quantitative T- and B-cell deficiencies, late infections after allo-SCT (after day +100 following transplantation) predominate in patients with chronic GVHD. In the absence of GVHD, immunosuppressive treatment is tapered and finally discontinued. In these patients, infectious complications are supposed to occur rarely. We describe a patient who underwent HLA-mismatched, unrelated allo-SCT because of bcr-abl-posi-tive ALL and developed severe hepatic abscesses after immunosuppression had been discontinued 1 year earlier.
机译:异源SCT后的感染风险取决于潜在疾病,早期治疗的强度以及所选的移植方式。与接受常规化疗或自动SCT的患者相比,即使在造血重建后,感染的高风险也是特征。由于粘膜损伤,慢性GVHD患者主要是粒细胞功能缺陷,功能性无力以及定性和定量的T细胞和B细胞缺陷,异基因SCT后(移植后+100天后)的晚期感染占主导地位。在缺乏GVHD的情况下,免疫抑制治疗会逐渐减少,并最终终止。在这些患者中,感染并发症很少发生。我们描述了一名患者,该患者由于bcr-abl-阳性ALL而接受了HLA不匹配的,无关的all-SCT,并且在1年前停用免疫抑制后出现了严重的肝脓肿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号